TRAILER for #36, Turning down a dragon on Dragons' Den Dr Rhona Eskander co-founder of Parla toothpaste

Dr Rhona Eskander is what a strong, bold, and smart entrepreneur looks like. She exudes confidence in herself and in her industry disruptive ‘toothpaste’ Parla so much so that she even turned down investment from a dragon on Dragons' Den. A successful dentist with her own practice Chelsea Dental Clinic, and an influencer with over 100k followers on Instagram and regular TV appearances, Dr Rhona has created her own niche. She is unapologetically glamorous, who in no uncertain terms has been told to tone it down. In this episode #36 we talk about her fighting with society, breaking down stereotypes, her approach to ‘having it all’ and taking over the world. Such a positive and inspiring conversation. I hope it fills you with as much energy as it did me. ----------------------------------------- DR RHONA ESKANDER ----------------------------------------- Instagram: https://www.instagram.com/drrhonaeskander/ TikTok: https://www.tiktok.com/@drrhonaeskander Twitter: https://twitter.com/drrhonaeskander YouTube: https://www.youtube.com/c/DrRhonaEskander Websites: Parla: https://parlatoothpastetabs.com/ Personal: https://www.drrhonaeskander.com/ Dental Practice: https://www.chelseadentalclinic.co.uk/team/dr-rhona-eskander/ ------------------------------- FOLLOW ME ON ------------------------------- LinkedIn: https://www.linkedin.com/in/mariahvo/ Instagram:  https://www.instagram.com/mariahvo/ Twitter: https://twitter.com/mhvorostovsky HVO Search: https://www.hvosearch.com ------------------------------------------------------------------------------------------------------- Need help HIRING - head over to - http://www.hirewithmaria.com ------------------------------------------------------------------------------------------------------- LEAVE A REVIEW: If you’re listening on Apple Podcasts make sure to Follow, Rate, and leave a REVIEW. The best review will get a mention in the next episode!

There are no comments yet.

Please log in to write the first comment.